Study
Ginkgo Biloba's Effectiveness for Memory Issues in Seniors Remains Uncertain
Most recent studies show no consistent benefit of Ginkgo Biloba for cognitive decline or dementia in older adults.
Summary
In plain language
Researchers have investigated whether Ginkgo Biloba, a popular plant-based supplement, can help with memory problems and dementia in older adults. While Ginkgo Biloba has been used traditionally for various health conditions, recent research shows mixed results. In several long-term trials, most found no significant difference between Ginkgo Biloba and a placebo for improving memory or daily functioning. Some trials did report positive effects, but these were not consistent. This means that for seniors considering Ginkgo Biloba for cognitive health, its benefits are not reliably supported by current evidence. It's always a good idea to discuss any supplements with your healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study reviewed multiple clinical trials to assess Ginkgo Biloba's effectiveness for cognitive decline and dementia.
The study analyzed 36 trials, focusing on those that compared Ginkgo Biloba to a placebo in people with memory issues.
Results were inconsistent; most trials showed no significant improvement in memory or daily activities for those taking Ginkgo Biloba.
Despite its popularity, the evidence does not consistently support Ginkgo Biloba's benefits for cognitive health in seniors.
Given the mixed findings, seniors should discuss with their healthcare provider before starting any new supplement, especially if they are considering Ginkgo Biloba for memory issues.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Ginkgo Biloba's Effectiveness for Memory Issues in Seniors Remains Uncertain
Published January 2009 · DOI 10.1002/14651858.cd003120.pub3
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored June 24, 2026 using rubric mq-1.5_2026-06-18.
Assessment
The study scored highly in study design, transparency, and journal quality due to its systematic review nature and publication in a reputable source. Bias control was moderate due to variability in included trials' quality. Statistical integrity was strong, with comprehensive meta-analytic methods. However, conflicts scored poorly due to the absence of a clear COI statement. The study is highly relevant to the target population of seniors.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 0.0/10 | |
| Replication | 10.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 10.0/10 |
Additional Notes
This Cochrane systematic review evaluates the efficacy and safety of Ginkgo biloba for dementia and cognitive impairment, finding inconsistent evidence of benefit and no significant adverse effects compared to placebo.
Assessed on a large portion of the study text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Supplements
Supplements help fill nutritional gaps and support healthy aging. For seniors, vitamins, minerals, and omega-3s can enhance bone strength, heart health, energy, and immune function when used safely under professional guidance.
Herbal Medicine
Herbal medicine uses plants and natural extracts to promote healing and overall wellness. For seniors, herbal remedies can support digestion, reduce inflammation, ease stress, and complement conventional treatments safely when used responsibly.
Ginkgo Biloba
Ginkgo biloba is an ancient herbal extract used to improve memory, focus, and blood flow. It supports cognitive performance and circulation, particularly in older adults.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.